Destination Access Sprycel (Dasatinib)
Bristol Myers-Squibb
OpenVerified·Mar 20, 2026
This page lists the Destination Access Sprycel (Dasatinib) grant as a program offered by Bristol Myers-Squibb. However, the page does not provide details on what the grant covers, its specific eligibility requirements, or how to apply.
- Enrollment cycle
- unknown
Apply
Application goes directly to Bristol Myers-Squibb. RxCopays does not receive compensation.
Go to application →Status source
Destination Access Sprycel (Dasatinib) - Bristol Myers-Squibb
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: